Lipoxin A4 analogue protects brain and reduces inflammation in a rat model of focal cerebral ischemia reperfusion
Lipoxin A4 analogue protects brain and reduces inflammation in a rat model of focal cerebral ischemia reperfusion
复制标题
DOI:
10.1016/j.brainres.2010.01.079
复制
发表时间:
2010-04
期刊:
影响因子:
2.9
通讯作者:
Xi-hong Ye;Yan Wu;Peipei Guo;Jie Wang;Shi-ying Yuan;You Shang;S. Yao
中科院分区:
文献类型:
--
作者:
Xi-hong Ye;Yan Wu;Peipei Guo;Jie Wang;Shi-ying Yuan;You Shang;S. Yao
Inflammation, which is known to be detrimental to the neurological outcome during the acute phase after ischemia, provides a potential preventative or therapeutic approach for acute stroke. Lipoxins are endogenous lipoxygenase derived eicosanoids and evokes protective actions in a range of pathophysiologic processes. Here, we evaluated the efficacy of 5 (S), 6 (R)-lipoxin A4methyl ester (LXA4ME), a stable synthetic analogue of lipoxin A4in cerebral ischemia reperfusion injury in rats. Transient focal cerebral ischemia was induced by middle cerebral artery occlusion for 2h. Intracerebroventricular administration of LXA4ME immediately after onset of ischemia ameliorated neurological dysfunctions, reduced infarction volume and attenuated neuronal apoptosis. Moreover, Treatment with LXA4ME suppressed neutrophils infiltration and lipid peroxidation levels; inhibited the activation of microglia and astrocytes; reduced the expression of pro-inflammatory cytokines TNF-α and IL-1β; and up-regulated the expression of anti-inflammatory cytokines IL-10 and TGF-β1 in the ischemic brain. In addition, activation of NF-κΒ was inhibited by LXA4ME treatment. These results demonstrate that treatment of LXA4ME affords strong neuroprotective effect against cerebral ischemia reperfusion injury, and that these effects might be associated with its anti-inflammatory property.